AngioGenex, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$138.49B

26 transactions

Summary

AngioGenex, Inc. is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $75.2MSales: —7 insiders

Date	Insider	Type	Value
2021-08-31	ARONSTEIN MICHAEL	A	$75.00B
2021-03-02	ARONSTEIN MICHAEL	A	$40.00B
2019-12-30	ARONSTEIN MICHAEL	A	$6.25B
2019-10-23	ARONSTEIN MICHAEL	A	$6.25B
2021-06-08	ARONSTEIN MICHAEL	A	$5.68B
2021-07-06	Strage Michael M(Vice President)	A	$4.05B
2020-10-08	ARONSTEIN MICHAEL	A	$555.5M
2020-08-05	ARONSTEIN MICHAEL	A	$500.0M
2020-03-03	ARONSTEIN MICHAEL	A	$125.0M
2019-01-15	Strage Michael M(Vice President)	A	$263K
2021-09-02	ARONSTEIN MICHAEL	A	$260K
2019-01-15	ARONSTEIN MICHAEL	Buy	$200K
2019-01-15	ARONSTEIN MICHAEL	A	$120K
2021-11-02	ARONSTEIN MICHAEL	A	$60K
2021-09-02	Dickey Robert IV	A	$33K
2021-09-02	Strage Michael M(Vice President)	A	$33K
2019-01-15	Murray Martin(Secretary, Treasurer, CFO)	A	$26K
2021-09-02	Murray Martin(Secretary, Treasurer, CFO)	A	$7K
2009-07-09	Salvador Richard(President)	A	$0
2009-07-09	Garland William A(CEO, COO)	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

AngioGenex, Inc. — Contributions, Lobbying & Contracts | Poliscope